NASDAQ:AARD - Nasdaq - US0029421007 - Currency: USD
10.13 +0.61 (+6.41%)
After market: 10.63 +0.5 (+4.94%)
SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (“Aardvark”) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused...